These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 25459460)

  • 1. The effect of increased vocal intensity on interarticulator timing in speakers with Parkinson’s disease: a preliminary analysis.
    Richardson K; Sussman JE; Stathopoulos ET
    J Commun Disord; 2014; 52():44-64. PubMed ID: 25459460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased vocal intensity due to the Lombard effect in speakers with Parkinson's disease: simultaneous laryngeal and respiratory strategies.
    Stathopoulos ET; Huber JE; Richardson K; Kamphaus J; DeCicco D; Darling M; Fulcher K; Sussman JE
    J Commun Disord; 2014; 48():1-17. PubMed ID: 24438910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sentence intelligibility before and after voice treatment in speakers with idiopathic Parkinson's disease.
    Cannito MP; Suiter DM; Beverly D; Chorna L; Wolf T; Pfeiffer RM
    J Voice; 2012 Mar; 26(2):214-9. PubMed ID: 22209057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of Speech Amplification Devices in Parkinson's Disease.
    Andreetta MD; Adams SG; Dykstra AD; Jog M
    Am J Speech Lang Pathol; 2016 Feb; 25(1):29-45. PubMed ID: 26847491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of vocal symptoms in Parkinson's disease: the Lee Silverman method].
    Dias AE; Limongi JC
    Arq Neuropsiquiatr; 2003 Mar; 61(1):61-6. PubMed ID: 12715021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing disordered speech and voice in Parkinson's disease: a telerehabilitation application.
    Constantinescu G; Theodoros D; Russell T; Ward E; Wilson S; Wootton R
    Int J Lang Commun Disord; 2010; 45(6):630-44. PubMed ID: 20102257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acoustic and perceptual speech characteristics of native Mandarin speakers with Parkinson's disease.
    Hsu SC; Jiao Y; McAuliffe MJ; Berisha V; Wu RM; Levy ES
    J Acoust Soc Am; 2017 Mar; 141(3):EL293. PubMed ID: 28372040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acoustic investigation of stress patterns in Parkinson's disease.
    Tykalova T; Rusz J; Cmejla R; Ruzickova H; Ruzicka E
    J Voice; 2014 Jan; 28(1):129.e1-129.e8. PubMed ID: 24094802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Respiratory Responses to Two Voice Interventions for Parkinson's Disease.
    Richardson K; Huber JE; Kiefer B; Kane C; Snyder S
    J Speech Lang Hear Res; 2022 Oct; 65(10):3730-3748. PubMed ID: 36167066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of intensive speech treatment on Mandarin speakers with Parkinson's Disease: A review.
    Chen Q; Chen B; Wan Q; Wang Y; Li J; Huang Z
    Medicine (Baltimore); 2023 Feb; 102(6):e32900. PubMed ID: 36820601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acoustic characteristics in relation to intelligibility reduction in noise for speakers with Parkinson's disease.
    Chiu Y; Neel A; Loux T
    Clin Linguist Phon; 2021 Mar; 35(3):222-236. PubMed ID: 32539544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acoustic and Perceptual Consequences of Speech Cues for Mandarin Speakers With Parkinson's Disease.
    Hsu SC; McAuliffe MJ; Lin P; Wu RM; Levy ES
    Am J Speech Lang Pathol; 2019 May; 28(2):521-535. PubMed ID: 31136238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of a simulated fMRI environment on voice intensity in individuals with Parkinson's disease hypophonia and older healthy adults.
    Manes JL; Herschel E; Aveni K; Tjaden K; Parrish T; Simuni T; Corcos DM; Roberts AC
    J Commun Disord; 2021; 94():106149. PubMed ID: 34543846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acoustic and perceptual correlates of faster-than-habitual speech produced by speakers with Parkinson's disease and multiple sclerosis.
    Kuo C; Tjaden K; Sussman JE
    J Commun Disord; 2014; 52():156-69. PubMed ID: 25287378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Consonant articulation acoustics and intelligibility in Swedish speakers with Parkinson's disease: a pilot study.
    Johansson IL; Samuelsson C; Müller N
    Clin Linguist Phon; 2023 Sep; 37(9):845-865. PubMed ID: 35833475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parkinson's disease: speech and voice disorders and their treatment with the Lee Silverman Voice Treatment.
    Ramig LO; Fox C; Sapir S
    Semin Speech Lang; 2004 May; 25(2):169-80. PubMed ID: 15118943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of Hypophonia in Parkinson's Disease Through Biofeedback in Daily Life Administered with A Portable Voice Accumulator.
    Gustafsson JK; Södersten M; Ternström S; Schalling E
    J Voice; 2024 May; 38(3):800.e27-800.e38. PubMed ID: 34893384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sensorimotor adaptation of voice fundamental frequency in Parkinson's disease.
    Abur D; Lester-Smith RA; Daliri A; Lupiani AA; Guenther FH; Stepp CE
    PLoS One; 2018; 13(1):e0191839. PubMed ID: 29373589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of group music therapy on mood, speech, and singing in individuals with Parkinson's disease--a feasibility study.
    Elefant C; Baker FA; Lotan M; Lagesen SK; Skeie GO
    J Music Ther; 2012; 49(3):278-302. PubMed ID: 23259231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of an extended version of the lee silverman voice treatment on voice and speech in Parkinson's disease.
    Spielman J; Ramig LO; Mahler L; Halpern A; Gavin WJ
    Am J Speech Lang Pathol; 2007 May; 16(2):95-107. PubMed ID: 17456888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.